Elisabeth Bjork, a director at $RCKT, bought 10,000 shares of the company on 08-27-2025 for an estimated $34,100. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 33.3%. Following this trade, they now own 40,000 shares of this class of $RCKT stock.
$RCKT Insider Trading Activity
$RCKT insiders have traded $RCKT stock on the open market 25 times in the past 6 months. Of those trades, 3 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $RCKT stock by insiders over the last 6 months:
- GAURAV SHAH (CEO) has made 1 purchase buying 20,000 shares for an estimated $101,600 and 2 sales selling 5,874 shares for an estimated $38,160.
- KINNARI PATEL (See Remarks) has made 1 purchase buying 21,099 shares for an estimated $99,165 and 2 sales selling 2,176 shares for an estimated $14,142.
- JONATHAN DAVID SCHWARTZ (See Remarks) has made 0 purchases and 5 sales selling 16,029 shares for an estimated $56,746.
- MARTIN WILSON (General Counsel) has made 0 purchases and 5 sales selling 15,234 shares for an estimated $51,355.
- AARON ONDREY (Chief Financial Officer) has made 0 purchases and 2 sales selling 8,966 shares for an estimated $43,903.
- JOHN MILITELLO (See Remarks) has made 0 purchases and 6 sales selling 9,833 shares for an estimated $36,203.
- ELISABETH BJORK purchased 10,000 shares for an estimated $34,100
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RCKT Hedge Fund Activity
We have seen 118 institutional investors add shares of $RCKT stock to their portfolio, and 160 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 12,626,491 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,934,902
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 4,820,701 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $11,810,717
- JANUS HENDERSON GROUP PLC removed 3,255,590 shares (-98.9%) from their portfolio in Q2 2025, for an estimated $7,976,195
- MAVERICK CAPITAL LTD added 3,164,595 shares (+60.9%) to their portfolio in Q2 2025, for an estimated $7,753,257
- MPM BIOIMPACT LLC added 2,284,816 shares (+141.2%) to their portfolio in Q2 2025, for an estimated $5,597,799
- NEWTYN MANAGEMENT, LLC added 2,000,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,900,000
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,943,853 shares (-63.9%) from their portfolio in Q2 2025, for an estimated $4,762,439
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RCKT Analyst Ratings
Wall Street analysts have issued reports on $RCKT in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 08/20/2025
- Chardan Capital issued a "Buy" rating on 08/20/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
- Canaccord Genuity issued a "Buy" rating on 07/25/2025
- UBS issued a "Buy" rating on 06/17/2025
- BMO Capital issued a "Outperform" rating on 05/28/2025
- Scotiabank issued a "Sector Outperform" rating on 05/28/2025
To track analyst ratings and price targets for $RCKT, check out Quiver Quantitative's $RCKT forecast page.
$RCKT Price Targets
Multiple analysts have issued price targets for $RCKT recently. We have seen 14 analysts offer price targets for $RCKT in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Geulah Livshits from Chardan Capital set a target price of $11.0 on 08/20/2025
- Jason Zemansky from B of A Securities set a target price of $10.0 on 08/20/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $8.0 on 08/08/2025
- Whitney Ijem from Canaccord Genuity set a target price of $10.0 on 07/25/2025
- Colin Bristow from UBS set a target price of $5.0 on 06/17/2025
- Andrew Tsai from Jefferies set a target price of $2.5 on 05/28/2025
- Kostas Biliouris from BMO Capital set a target price of $8.0 on 05/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
